Conference abstract · 8 Nov 2017
Conference abstractPublished 5 Mar 2018
ProxiMAX randomization: precision protein engineering
Aston University, UK
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
ProxiMAX randomization is the technology that lies behind Isogenica’s Colibra™ offering. It is a defined saturation mutagenesis process that delivers precision control of both identity and relative ratio of amino acids at specified locations within a protein/antibody library. Thus unwanted amino acids such as cysteine and methionine can be eliminated from libraries because no constraints are imposed by the genetic code. Moreover, the process is non-degenerate, which means that encoding DNA libraries are as small as is physically possible. ProxiMAX relies on a process of saturation cycling comprising ligation, amplification and digestion for each cycle and is the science behind the commercial Colibra™ technology. Currently focused on antibody libraries but with achieved diversities of >99% (6 & 11 saturated codons) and the potential to generate libraries of up to 1014 components, we contest that ProxiMAX randomization is a vital tool in engineering any protein library of the highest quality. This presentation will examine the development of the ProxiMAX process and give examples of libraries created to date. Reference 1. Ferreira Amaral M M, Frigotto L and Hine A V (2017) Beyond the natural proteome: nondegenerate saturation mutagenesis - methodologies and advantages. Meth. Enyzmol. 585:111-133. 2. Frigotto L, Smith M E, Brankin C, Sedani A, Cooper S E, Kanwar N, Evans D, Svobodova S, Baar C, Glanville J, Ullman C G and Hine A V (2015) Codon-precise, synthetic, antibody fragment libraries built using automated hexamer codon additions and validated through next generation sequencing. Antibodies 4:88-102. 3. Chimonides G F, Behrendt J M, Chundoo E, Bland C, Hine A V, Devitt A, Nagel D A and Sutherland A J (2014) Cellular uptake of ribonuclease A functionalised core–shell silica microspheres. J Mater Chem B, 2:7307-7315. 4. Nagel D, Behrendt J M, Chimonides G F, Torr E E, Devitt A, Sutherland A J and Hine A V (2014) Polymeric microspheres as protein transduction reagents. Mol. Cell Proteomics, 13:1543-1551. 5. Ashraf M, Frigotto L, Smith M E, Patel S, Hughes M D, Poole A J, Hebaishi H R M, Ullman C G and Hine A V (2013) ProxiMAX randomisation: a new technology for non-degenerate saturation mutagenesis of contiguous codons. Biochem. Soc. Trans. 41:1189-1194.
Subjects
EngineeringAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 8 Nov 2017
ProxiMAX randomization: Precision antibody engineering
Perspective · 30 Jun 2025
Scientific Progress in Genetic Engineering and its Contribution to Effective Disease Prevention and Precision Based Therapeutic Approaches
Perspective · 30 Jun 2025
Translating Molecular Insight into Clinical Practice through Precision Genetic Engineering for Complex Genetic and Infectious Diseases
Editorial · 31 May 2025
Engineering Drawing in Architectural Engineering: A Foundation for Precision and Creativity in Design
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectEngineering
- BylineArticles whose byline prints “Anna V Hine”
